Keywords: genemedicine, il-2, gene, enter, phase, reported, briefly

GeneMedicine's IL-2 Gene To Enter Phase I

Article | 17 February 1997

Print This

As was reported briefly in the Marketletter last week, GeneMedicine hasreceived clearance from the US Food and Drug Administration to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in